P Jiamsripong, M Mookadam, T Honda, BK … - Prev Cardiol, 2008 - interscience.wiley.com The metabolic syndrome is a constellation of metabolic risk factors and physical conditions that
are accompanied by an enhanced propensity toward the development of type 2 diabetes,
atherosclerosis, and cardiovascular disease. It presents a combination of atherosclerosis ... Cited by 3 - Related articles - All 3 versions
- ►diabetesjournals.org J Szendroedi, C Anderwald, M Krssak, M Bayerle- … - Diabetes care, 2009 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We performed a randomized, double-blind,
placebo-controlled, single-center study. Twenty patients with type 2 diabetes received 80 mg
simvastatin (BMI 29 ± 4 kg/m 2 , age 55 ± 6 years) or placebo (BMI 27 ± 4 kg/m 2 , age 58 ... Cited by 5 - Related articles - All 4 versions
KK Koh, MJ Quon, SH Han, Y Lee, JB Park, SJ Kim, … - International Journal of …, 2009 - Elsevier Atorvastatin combined with amlodipine or amlodipine alone significantly reduced blood pressure
to a greater extent than atorvastatin alone (all P < 0.001 by ANOVA). Atorvastatin combined with
amlodipine significantly reduced plasma malondialdehyde and improved flow-mediated ... Cited by 1 - Related articles - All 2 versions
- ►nih.gov KK Koh, MJ Quon, SH Han, Y Lee, SJ Kim, JB Park, EK … - Atherosclerosis, 2009 - Elsevier Simvastatin and pravastatin therapy significantly changed lipoprotein levels and improved
flow-mediated dilation after 2 months when compared with baseline (P < 0.001) or placebo treatment
(P < 0.001 by ANOVA). Simvastatin therapy significantly increased insulin levels (mean % ... Cited by 2 - Related articles - All 54 versions
M Yilmaz, N Bukan, H Demirci, Ç Öztürk, E … - Gynecological …, 2009 - informahealthcare.com Results. Plasma resistin levels, HOMA-IR and AUCI were significantly higher and adiponectin
level was lower in women with PCOS than those in healthy women. Plasma resistin levels were
similar among obese and non-obese women with PCOS. No correlation was observed ... Cited by 1 - Related articles - All 6 versions
SH Han, I Sakuma, EK Shin, KK Koh - Progress in Cardiovascular Diseases, 2009 - Elsevier Adiponectin is a protein secreted by adipose cells that may couple regulation of insulin sensitivity
with energy metabolism and serve to link obesity with insulin resistance. Obesity-related disorders
characterized by insulin resistance including the metabolic syndrome, diabetes, ... Related articles - All 35 versions
T Tsutamoto, M Yamaji, C Kawahara, K … - European Journal of …, 2009 - eurjhf.oxfordjournals.org Methods and results: Seventy-one stable outpatients with NICHF, who were already receiving
standard therapy for CHF, were randomized to simvastatin (n = 35) or rosuvastatin (n = 36). Plasma
levels of brain natriuretic peptide (BNP), total adiponectin, high-sensitive C-reactive ...
F Montecucco, F Mach - Diabetes, Obesity and Metabolism, 2009 - pt.wkhealth.com The history of the metabolic syndrome seems directly linked to improvements in lifestyle. Characteristics
of metabolic syndrome were described for the first time in the 1923 by Kylin [1]. In 1947, Vague
observed that central and android adiposity were associated with metabolic alterations in ... Related articles
MD Bayerle-Eder, H Esterbauer, GP PhD, AB MD, PN … - Diabetes Care - Am Diabetes Assoc Julia Szendroedi, MD, PhD1,2, Christian Anderwald, Mag, MD1, Martin Krssak, PhD1, Michaela
Bayerle-Eder, MD1, Harald Esterbauer, MD, PhD3, Georg Pfeiler, MD1, Attila Brehm, MD1, Peter
Nowotny1, Astrid Hofer1, Werner Waldhäusl, MD1, Michael Roden, MD2,4
Z Grąbczewska, J Kubica - Cardiology Journal, 2008 - viamedica.pl In the current issue of Cardiology Journal, Qi-ming Liu et al. [1] present the study in which they
prove that in the group of patients with microva- scular angina (myocardial ischemia without
steno- sis in coronary arteries confirmed by means of se- veral methods) more intense ... Related articles - View as HTML - All 2 versions
